The Croda Pharma promise
As a leading partner for the development of excipients and the supply of high purity materials for pharmaceutical formulations, we are committed to enabling the next generation of drug delivery systems. As a business, we are focused on empowering biologics drug delivery, through our adjuvant systems, small molecule, protein, and nucleic acid delivery platforms. With a wide range of solutions for both human and animal health markets, our pharmaceutical portfolio is unsurpassed in its excellence for drug and vaccine delivery. Our products, along with our in-house formulation and regulatory expertise, allow us to meet our customers most demanding formulation needs.
Driving a sustainable future
As a part of Croda, our purpose is to use Smart science to improve lives™, enabled by our distinctive values-led culture that governs how we work with one another and guides our relationships with all of our partners. We combine our knowledge, passion and entrepreneurial spirit to create, make and sell speciality ingredients that are relied on by industries and consumers everywhere.
2030 target
We are committed to being the most sustainable supplier of innovative ingredients.
Reducing emissions
We will reduce carbon emissions aligned to our verified Science Based Target, supporting our customers with their Net Zero goals.
Health and wellbeing
We will contribute to the successful development and commercialisation of 25% of World Health Organization (WHO) listed pipeline vaccines.
People positive
We use our smart science to improve the lives of our own employees and people all around the world. We will contribute to SDG 3, developing ingredients to improve health and wellbeing, provide access to our smart science through our foundation, and encourage and promote diversity within our organisation. We will continue to innovate to increase our positive impact on society.
Driving the pipeline of vaccines for 2024
We are proud to contribute to our target milestone for 2024, which is to ensure our technology will be part of at least 10 clinical phase III trials for at least 25% of the WHO listed pipeline vaccines. Despite the acceleration of the vaccine development cycle driven by the critical requirements to develop a vaccine for COVID-19, the ongoing ‘baseline’ for current clinical trials across the WHO priority diseases is currently in low single figures. For our products to be included in 10 clinical trials during 2024 sets us a significant challenge for the next few years.
How we empower biologics delivery
The race to beat COVID-19
As COVID-19 surged across the world, our team fought against time to get critical materials ready for the worlds leading vaccines.
Watch the story unfold in our mini documentary.
Our markets
Our Purpose, Smart science to improve lives™ is at the core of our Human and Veterinary market strategy.
Learn moreWho we are
Established in 1925, Croda is the name behind high performance ingredients and technologies in some of the world’s biggest and most successful brands: creating, making, and selling speciality chemicals that are relied on by industries and consumers everywhere.
Learn more